
Respiratory
20 Jun 2025
Dupilumab Flagged for Higher Lymphoma Risk in Asthma
A population-based cohort study finds that asthma patients treated with dupilumab may face an increased risk of developing lymphoma, particularly T and natural killer (NK) cell subtypes, compared to those treated with standard combination inhalers.